Navigation Links
7th Annual Reglera Reproductive Compliance Conference Slated for September 19-20, in Arlington, Virginia
Date:5/31/2013

Arlington, Virginia (PRWEB) May 31, 2013

Reglera, LLC recently announced its 7th Reproductive Regulatory Compliance Conference is slated to be held September 19-20, 2013 at the Crystal City Marriott with complimentary airport shuttle and direct Metro access to downtown Washington, DC.

New to the conference this year, The Reproductive Compliance Conference will feature interactive sessions with live audience polls to challenge attendees’ knowledge of the current tissue regulations. Focused group discussions will encourage and facilitate in-depth dialogue and networking among participants.

Specific presentation topics will include (but are not limited to) the following:
Demystifying Donor Requirements
Donor Testing Requirements
Trends in the Industry: Working with Donor Banks and Agencies
Establishing Procedures
Enforcement Activity including recent Orders to Cease Manufacturing and Warning Letters

Reglera Presenters are experts in the reproductive regulatory field including:
Clay Anselmo, RAC, President
Martha Wells, MPH, RAC-VP of Regulatory Affairs for Tissue and Biologics
Rich Weiskopf, RAC, Senior Quality Assurance Director
Amy Johnson, CTBS, Tissue Services Manager
Cindy Blinci, CTBS, CQA (ASQ), Tissue Specialist

To secure your attendance at the Reproductive Compliance Conference 2013, visit the registration page on Reglera’s website, http://www.reglera.com. Space is limited and reservations will be made on a first-come first-served basis. For questions regarding the conference, please email John Dupont at dupontjo(at)reglera(dot)com or call (303) 832-8200.

--------------------------------------------------------------------------------

About Reglera: Based in Wheat Ridge, Colorado, Reglera, a Dohmen Company, provides best practice compliance and quality assurance services to more than 500 hundred medical device and human cellular tissue companies. With one of the largest consulting staffs in the industry including hundreds of experts in device and tissue located in the US and Israel, Reglera has helped both small start-ups and global corporations accelerate growth and profitability with comprehensive consulting and outsourcing services. For more information regarding Reglera services, visit http://www.reglera.com or contact Brian Tucker at 1.800.341.4255 or info(at)reglera(dot)com.

About Dohmen: Founded in 1858, Dohmen is a privately-held, Life Science Services Company, focused on creating a more efficient, affordable and accessible healthcare supply system. As the trusted partner to more than 600 Biopharma, Medtech and advanced therapy innovators, Dohmen propels start-up, mid-tier and Fortune 500 companies with support services that span the commercialization continuum from pre-approval regulatory consulting to in-home patient services. With a tradition of innovation that spans over 155 years, we’re driven by the desire to reduce cost and complexity within today’s healthcare system, using a progressive model that connects life science companies with the patients they serve.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10787362.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Policy Meets Practice at 23th Annual Maine Geriatrics Conference
2. Connecticut Community for Addiction Recovery Pays Tribute to Volunteers at 8th Annual Recognition Celebration: Community Members Honored For 23,000 Hours of Service
3. Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Sixth Annual One Day Sale on Gift Certificates Will Take Place on June 19, 2013
4. TalkWorthy Radio Show Interviews Alex Brown and Erin Gillen about the 5th Annual Utah 5K VisionWalk on June 15 In Salt Lake City
5. eHealthcare Solutions Hosts Second Annual Publisher Summit
6. Pawtucket Family YMCA to Host Annual Block Party
7. Latest sleep research to be presented June 2 - 5 at annual meeting in Baltimore
8. Octo Consulting Group to Present at the Annual Semantic Technology & Business Conference in San Francisco
9. HealthEconomics.Com Distinguished As Top Influencer at the International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting
10. Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California
11. AUA Celebrates Seventh Annual Commencement Ceremony
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The International ... 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected ... will be showcased and the winner revealed at the 31st annual iaedp Symposium, March ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, ... their Military Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, ... generously donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which ... participating in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates ... a website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients ...
(Date:2/23/2017)... ... 23, 2017 , ... EBSCO Information Services (EBSCO) ... for Health and Care Excellence (NICE) framework. The agreement allows purchasers from ... to search, order and purchase medical and healthcare-related content through GOBI ®, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that it will soon begin franchising throughout the U.S. starting this spring. ... help bring the practice of meditation mainstream. Current Meditation will be the first ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ( ... diversifiée innovante, est ravie d,annoncer les excellents résultats semestriels ... période précédente correspondante. Une présentation complète « Résultats et mise ... consultée ici . Faits marquants ... 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
Breaking Medicine Technology: